East Buy (01797.HK) soared 5.06% intraday, reflecting a significant rebound in investor confidence.

The surge follows the company's "Nutrition Verification Conference" where it unveiled multiple health supplements with Blue Hat certification and announced the progressive launch of seven self-branded cross-border health food products. The company also disclosed that its self-developed product portfolio has exceeded 800 SKUs, with a user base surpassing 30.86 million.

Additionally, recent key management restructuring has stabilized the leadership framework, with the new team fully taking over operational management. These developments appear to have alleviated previous investor concerns about the company's potential shift to a capital-heavy brick-and-mortar strategy, refocusing market attention on its core direct-to-consumer and self-branded category expansion strategy.